Nuwellis Inc vs VanEck Rare Earth/Strategic Metals — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while VanEck Rare Earth/Strategic Metals trades at $61.8 (market cap $1.75B). The key difference: VanEck Rare Earth/Strategic Metals is far larger — about 795.5× Nuwellis Inc's market cap, and VanEck Rare Earth/Strategic Metals is more actively traded (930,523 versus 121,544). Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and VanEck Rare Earth/Strategic Metals for 50 Days on average.
| NUWE | REMX | |
|---|---|---|
Market Cap | $2.20M | $1.75B |
Volume | 121,544 | 930,523 |
Sector | Health | Sector/Thematic |
52-Week High | $146.65 | $109.53 |
52-Week Low | $0.68 | $60.58 |
Typical Hold Time | 26 Days | 50 Days |
Enterprise Value | -$1.52M | — |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
REMX (VanEck Rare Earth and Strategic Metals ETF) is trading at $61.88, down 2.99% with a bearish technical signal. The ETF faces selling pressure across moving averages and oscillators, though RSI readings below 23 suggest potential oversold conditions. Recent news highlights increased institutional interest from Bank of America while the rare earth sector navigates geopolitical tensions and U.S. supply chain developments.
The ETF's high volatility (~50% annualized) and China-heavy exposure present significant risks, though strategic importance of rare earth metals for defense and technology offers long-term thematic appeal. Current technical weakness contrasts with fundamental tailwinds from U.S. supply chain initiatives, creating a contested investment case requiring careful risk assessment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.
Read more on REMX →